We are live on ! Find out more
CIC

Carnegie Investment Counsel Portfolio holdings

AUM $4.99B
1-Year Est. Return 23.08%
This Fund
S&P 500
This Quarter Est. Return
+2.08%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$1.57B
AUM Growth
+$30.3M
Cap. Flow
+$7.86M
Cap. Flow %
0.5%
Top 10 Hldgs %
19.76%
Holding
438
New
16
Increased
166
Reduced
176
Closed
21

Sector Composition

Rank Sector Weight
1 Financials 14.6%
2 Technology 12.75%
3 Industrials 11.5%
4 Healthcare 8.97%
5 Consumer Discretionary 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
201
Automatic Data Processing
ADP
$108B
$1.13M 0.07%
7,024
-3,634
-34% -$600K
DFS
202
DELISTED
Discover Financial Services
DFS
$1.13M 0.07%
13,977
-225
-2% -$18.6K
CMG icon
203
Chipotle Mexican Grill
CMG
$40.5B
$1.13M 0.07%
66,950
-7,500
-10% -$120K
PPG icon
204
PPG Industries
PPG
$25.8B
$1.12M 0.07%
9,418
-1,000
-10% -$115K
IBMK
205
DELISTED
iShares iBonds Dec 2022 Term Muni Bond ETF
IBMK
$1.11M 0.07%
42,302
-3,915
-8% -$103K
UGI icon
206
UGI
UGI
$7.54B
$1.1M 0.07%
21,815
+11,315
+108% +$565K
UPS icon
207
United Parcel Service
UPS
$88.8B
$1.09M 0.07%
9,117
-5,381
-37% -$615K
STWD icon
208
Starwood Property Trust
STWD
$6.17B
$1.08M 0.07%
44,650
+100
+0.2% +$2.36K
WBA
209
DELISTED
Walgreens Boots Alliance
WBA
$1.07M 0.07%
19,285
-1,726
-8% -$92.5K
EDIT icon
210
Editas Medicine
EDIT
$453M
$1.06M 0.07%
46,740
+6,750
+17% +$167K
MZTI
211
The Marzetti Company
MZTI
$3.15B
$1.06M 0.07%
7,670
-288
-4% -$42.9K
GIS icon
212
General Mills
GIS
$20.2B
$1.06M 0.07%
19,233
+518
+3% +$27.9K
XYL icon
213
Xylem
XYL
$28.8B
$1.05M 0.07%
13,252
+8,994
+211% +$707K
NVS icon
214
Novartis
NVS
$294B
$1.04M 0.07%
11,924
-425
-3% -$38.2K
CRSP icon
215
CRISPR Therapeutics
CRSP
$5.23B
$1.03M 0.07%
25,170
+2,570
+11% +$123K
FBIN icon
216
Fortune Brands Innovations
FBIN
$5.97B
$1.02M 0.07%
21,824
-11,080
-34% -$503K
BF.B icon
217
Brown-Forman Class B
BF.B
$12.9B
$990K 0.06%
15,770
+1,065
+7% +$62.2K
IHI icon
218
iShares US Medical Devices ETF
IHI
$3.47B
$988K 0.06%
23,988
BSV icon
219
Vanguard Short-Term Bond ETF
BSV
$45.6B
$985K 0.06%
12,190
+125
+1% +$10.1K
WPC icon
220
W.P. Carey
WPC
$15.9B
$923K 0.06%
10,524
+4,424
+73% +$377K
HXL icon
221
Hexcel
HXL
$7.6B
$920K 0.06%
11,205
-100
-0.9% -$8.17K
CEM
222
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$893K 0.06%
15,694
+506
+3% +$29.4K
IBM icon
223
IBM
IBM
$225B
$879K 0.06%
6,323
-1,289
-17% -$174K
IXN icon
224
iShares Global Tech ETF
IXN
$9.2B
$872K 0.06%
28,278
-102
-0.4% -$3.1K
IBMI
225
DELISTED
iShares iBonds Sep 2020 Term Muni Bond ETF
IBMI
$871K 0.06%
34,125
-970
-3% -$24.8K

Similar funds

Carnegie Investment Counsel's Q3 2019 Portfolio in Review

As of Q3 2019, Carnegie Investment Counsel held 438 positions worth $1.57B, up 2% from $1.54B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Carnegie Investment Counsel's Q3 2019 filing shows 16 new, 166 increased, 176 reduced and 21 closed positions. Its largest new stake was Smartsheet Inc.: 40,000 shares worth $1.44M. The largest sale was Berkshire Hathaway Class B, an estimated $7.12M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

  • Carnegie Investment Counsel's largest Q3 2019 buy was Smartsheet Inc.: 40,000 shares worth $1.44M.
  • Carnegie Investment Counsel added most to Schwab Short-Term US Treasury ETF in Q3 2019, an estimated $9.27M increase.
  • Carnegie Investment Counsel's biggest Q3 2019 reduction was Berkshire Hathaway Class B, cutting an estimated $7.12M.
  • Carnegie Investment Counsel fully exited iShares 20+ Year Treasury Bond ETF in Q3 2019, selling an estimated $2.93M.
  • Carnegie Investment Counsel's ten largest holdings make up 20% of its $1.57B portfolio in Q3 2019.
  • Carnegie Investment Counsel opened 16 new positions and closed 21 in Q3 2019.
  • Carnegie Investment Counsel's portfolio value rose 2% quarter-over-quarter to $1.57B.

Based on Carnegie Investment Counsel's 13F filing for Q3 2019, filed 20 Nov 2019.